Loading...

Less is more: lymphodepletion followed by hematopoietic stem cell transplant augments adoptive T-cell-based anti-tumor immunotherapy

Adoptive T-cell immunotherapy combined with non-myeloablative lymphodepletion has emerged as the most effective immunotherapy treatment for patients with metastatic melanoma (objective response rates of 50%). The mechanisms underlying this major advance in the field of immunotherapy include the elim...

Full description

Saved in:
Bibliographic Details
Main Authors: Wrzesinski, Claudia, Restifo, Nicholas P
Format: Artigo
Language:Inglês
Published: 2005
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2254579/
https://ncbi.nlm.nih.gov/pubmed/15766681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2005.02.002
Tags: Add Tag
No Tags, Be the first to tag this record!